Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd Hinjawadi, Pune, India, Mfg for: Heritage Pharmaceuticals Inc. UPC 323155216388, NDC 23155-216-31
Published October 31, 2018 · Recall initiated: October 15, 2018
Summary
FDA records drug Class II recall D-0094-2019, published October 31, 2018 and initiated October 15, 2018. Recalling firm: Heritage Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 2,789 Units; Lot: Lot #: VCIA083, Exp. JUN2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle
What to do
Voluntary: Firm initiated · Letter
Get an email if CIDOFOVIR DIHYDRATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CIDOFOVIR DIHYDRATE
- Manufacturer
- Heritage Pharmaceuticals, Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0323155216318
- Lot
- Lot #: VCIA083, Exp. JUN2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAmlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDCOctober 31, 2018
- FDAMeropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Sterile, Rx Only, Manufactured for:October 31, 2018
- FDAFluocinolone Acetonide Topical Solution, USP 0.01%, 60ml Bottle, Manufactured for: Lupin Pharmaceutical, Inc.October 31, 2018
- FDAPaliperidone Extended Release Tablets 3 mg, packaged in a) 30-count bottle(NDC 0591-3693-30), b) 90-countOctober 31, 2018
- FDACyclosporine 1% Human Eye Drops, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-2776-92October 31, 2018
- FDAPaliperidone Extended Release Tablets 9 mg, packaged in a) 30-count bottle(NDC 0591-3695-30) , b) 90-countOctober 31, 2018
Questions about this recall
Was Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd Hinjawadi, Pune, India, Mfg for: Heritage Pharmaceuticals Inc. UPC 323155216388, NDC 23155-216-31 recalled?
Yes. FDA published recall D-0094-2019 on October 31, 2018. Reported hazard: Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CIDOFOVIR DIHYDRATE. UPC: 0323155216318.